Phase III FIRSTâ¢ (MM-020/IFM 07-01) Trial of REVLIMIDÂ® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Med